Inhibitory functioning in Alzheimer's disease

被引:213
|
作者
Amieva, H
Phillips, LH
Della Sala, S
Henry, JD
机构
[1] Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France
[2] Univ Aberdeen, Dept Psychol, Aberdeen AB9 1FX, Scotland
关键词
inhibition; ageing; dementia; Alzheimer's disease;
D O I
10.1093/brain/awh045
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present a comprehensive review of studies assessing inhibitory functioning in Alzheimer's disease. The objectives of this review are: (i) to establish whether Alzheimer's disease affects all inhibitory mechanisms equally, and (ii) where possible, to assess whether any effects of Alzheimer's disease on inhibition tasks might be caused by other cognitive deficits, such as slowed processing. We review inhibitory mechanisms considered to play a crucial role in various domains of cognition, such as inhibition involved in working memory, selective attention and shifting abilities, and the inhibition of motor and verbal responses. It was found that whilst most inhibitory mechanisms are affected by the disorder, some are relatively preserved, suggesting that inhibitory deficits in Alzheimer's disease may not be the result of a general inhibitory breakdown. In particular, the experimental results reviewed showed that Alzheimer's disease has a strong effect on tasks requiring controlled inhibition processes, such as the Stroop task. However, the presence of the disease appears to have relatively little effect on tasks requiring more automatic inhibition, such as the inhibition of return task. Thus, the distinction between automatic, reflexive inhibitory mechanisms and controlled inhibitory mechanisms may be critical when predicting the integrity of inhibitory mechanisms in Alzheimer's disease. Substantial effects of Alzheimer's disease on tasks such as negative priming, which are not cognitively complex but do require some degree of controlled inhibition, support this hypothesis. A meta-analytic review of seven studies on the Stroop paradigm revealed substantially larger effects of Alzheimer's disease on the inhibition condition relative to the baseline condition, suggesting that these deficits do not simply reflect general slowing.
引用
收藏
页码:949 / 964
页数:16
相关论文
共 50 条
  • [31] Alzheimer's disease and depression:: Preclinical comorbidity effects on cognitive functioning
    Berger, AK
    Fratiglioni, L
    Winblad, B
    Bäckman, L
    CORTEX, 2005, 41 (04) : 603 - 612
  • [32] Longitudinal assessment of neuropsychiatric functioning in patients with schizophrenia and Alzheimer's disease
    Fleming, K
    Nielson, K
    Nilsson, M
    Kalali, A
    Sandman, C
    Potkin, SG
    Bunney, W
    SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 102 - 103
  • [33] Dissociation between visuospatial and visuoperceptual functioning in Alzheimer's disease.
    Andrikopoulos, J
    CLINICAL NEUROPSYCHOLOGIST, 1996, 10 (03): : 321 - 321
  • [34] The Relationship Among Arachidonic Acid, Executive Functioning, and Alzheimer's Disease
    Junod, A.
    DeBoard, Marion S.
    Harrington, M.
    Fonteh, A.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2013, 28 (06) : 556 - 557
  • [35] Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease.
    McBride, T
    Moberg, PJ
    Mahr, R
    Arnold, SE
    Gur, RE
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 57 - 58
  • [36] Olfactory functioning in Alzheimer's disease, vascular dementia, and major depression
    Duff, K
    McCaffrey, RJ
    Solomon, GS
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2000, 15 (08) : 709 - 709
  • [37] Introductory editorial to the special issue: Alzheimer's disease biomarkers and cognitive functioning along the Alzheimer's continuum
    Butts, Alissa M.
    Haut, Marc W.
    AGING NEUROPSYCHOLOGY AND COGNITION, 2023, 30 (06) : 861 - 865
  • [38] Effects of nicotinic cholinergic agents on cognitive functioning in Alzheimer's and Parkinson's disease
    Newhouse, P
    Potter, A
    Corwin, J
    DRUG DEVELOPMENT RESEARCH, 1996, 38 (3-4) : 278 - 289
  • [39] Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer's disease
    Kurucu, Hatice
    Colom-Cadena, Marti
    Davies, Caitlin
    Wilkins, Lewis
    King, Declan
    Rose, Jamie
    Tzioras, Makis
    Tulloch, Jane H.
    Smith, Colin
    Spires-Jones, Tara L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (05) : 1311 - 1323
  • [40] Early involvement of small inhibitory cortical interneurons in Alzheimer’s disease
    Vassilis E. Koliatsos
    Aleksandar Kecojevic
    Juan C. Troncoso
    Myriam C. Gastard
    David A. Bennett
    Julie A. Schneider
    Acta Neuropathologica, 2006, 112 : 147 - 162